Topical Tranexamic Acid versus Phenylephrine-lidocaine for the Treatment of Anterior Epistaxis in Patients Taking Aspirin or Clopidogrel; a Randomized Clinical Trial
Archives of Academic Emergency Medicine,
Vol. 9 No. 1 (2021),
1 January 2021
Introduction: Epistaxis is one of the most prevalent complaints in the emergency department (ED), especially in patients who take antiplatelet agents. This study aimed to compare the effect of topical use of tranexamic acid (TXA) with phenylephrine-lidocaine anterior nasal packing (PANP) in controlling epistaxis of patients who take aspirin or clopidogrel.
Methods: This prospective, double-blind, parallel-group, randomized clinical trial was conducted to compare the effect of topical use of intravenous (IV) TXA compared with PANP on controlling anterior epistaxis in patients who take aspirin or clopidogrel.
Results: One hundred patients with the mean age of 59.24 ± 7.75 (45 – 75) years were studied (52% male). Two groups were similar in terms of age (p=0.81) and sex (p=0.23) distribution, diabetes mellitus (p=0.54), and hypertension (p = 0.037). The mean time to stop bleeding was 6.70 ± 2.35 minutes in the TXA group and 11.50±3.64 minutes in the PANP group (p=0.002). Bleeding recurrence occurred in 3 (6%) cases of the TXA group and 10 (20%) cases of the PANP group (p =0.03). Time to discharge from ED in the TXA group was significantly lower than the PANP group (p<0.001). The absolute risk reduction (ARR), relative risk reduction, and number needed to harm of treatment with TXA for anterior nasal bleeding were 14.00% (95%CI: 1.11 – 26.89), 17.50% (95%CI: 0.60 - 37.27), and 7.14 (95%CI: 3.71 -90.43), respectively.
Conclusion: Topical TXA is an appropriate treatment option in bleeding cessation, and reducing re-bleeding and duration of hospital stay in patients with epistaxis who take antiplatelet agents.
- Tranexamic Acid; phenylephrine, lidocaine drug combination; Epistaxis; Aspirin; Clopidogrel; Emergency Medical Services
How to Cite
Viehweg TL, Roberson JB, Hudson J. Epistaxis: diagnosis and treatment. Journal of oral and maxillofacial surgery. 2006;64(3):511-8.
Chaaban MR, Zhang D, Resto V, Goodwin JS. Demographic, seasonal, and geographic differences in emergency department visits for epistaxis. Otolaryngology–Head and Neck Surgery. 2017;156(1):81-6.
Bell MD G. Management of Epistaxis. 2016.
Tabassom A, Cho JJ. Epistaxis (nose bleed). StatPearls [Internet]. 2020.
Svider P, Arianpour K, Mutchnick S. Management of epistaxis in children and adolescents: avoiding a chaotic approach. Pediatric Clinics. 2018;65(3):607-21.
Wojak JC, editor Endovascular Treatment of Epistaxis. Seminars in Interventional Radiology; 2020: Thieme Medical Publishers.
Runyon MS. Topical tranexamic acid for epistaxis in patients on antiplatelet drugs: a new use for an old drug. Academic Emergency Medicine. 2018;25(3):360-1.
Joseph J, Martinez‐Devesa P, Bellorini J, Burton MJ. Tranexamic acid for patients with nasal haemorrhage (epistaxis). Cochrane Database of Systematic Reviews. 2018(12).
Zahed R, Mousavi Jazayeri MH, Naderi A, Naderpour Z, Saeedi M. Topical tranexamic acid compared with anterior nasal packing for treatment of epistaxis in patients taking antiplatelet drugs: randomized controlled trial. Academic Emergency Medicine. 2018;25(3):261-6.
Tunkel DE, Anne S, Payne SC, Ishman SL, Rosenfeld RM, Abramson PJ, et al. Clinical practice guideline: nosebleed (epistaxis). Otolaryngology–Head and Neck Surgery. 2020;162(1_suppl):S1-S38.
Zhou AH, Chung SY, Sylvester MJ, Zaki M, Svider PS, Hsueh WD, et al. To pack or not to pack: inpatient management of epistaxis in the elderly. American journal of rhinology & allergy. 2018;32(6):539-45.
Sethi RK, Kozin ED, Abt NB, Bergmark R, Gray ST. Treatment disparities in the management of epistaxis in United States emergency departments. The Laryngoscope. 2018;128(2):356-62.
Timp JF, Braekkan SK, Lijfering WM, van Hylckama Vlieg A, Hansen J-B, Rosendaal FR, et al. Prediction of recurrent venous thrombosis in all patients with a first venous thrombotic event: The Leiden Thrombosis Recurrence Risk Prediction model (L-TRRiP). PLoS medicine. 2019;16(10):e1002883.
McGrath ER, Go AS, Chang Y, Borowsky LH, Fang MC, Reynolds K, et al. Use of oral anticoagulant therapy in older adults with atrial fibrillation after acute ischemic stroke. Journal of the American Geriatrics Society. 2017;65(2):241-8.
Cai J, Ribkoff J, Olson S, Raghunathan V, Al‐Samkari H, DeLoughery TG, et al. The many roles of tranexamic acid: An overview of the clinical indications for TXA in medical and surgical patients. European journal of haematology. 2020;104(2):79-87.
Abootalebi Ghahnavieh A, Tashayoie A, Nasr Esfahani M, Golshani K. Comparative Study of the Efficacy of Topical Tranexamic Acid with Nasal Tampon in Management of Epistaxis: A Randomized Clinical Trial. Scientific Journal of Kurdistan University of Medical Sciences. 2020;25(4):140-9.
Atabaki P, Soheili A, Aribi MS, Samarei R, Mehryar HR. A comparative study on the effect of topical phenylephrine with topical tranexamic acid in management of epistaxis. The J Urmia Nurs Midwifery Fac. 2017;15(7):488-96.
Whitworth K, Johnson J, Wisniewski S, Schrader M. Comparative Effectiveness of Topically Administered Tranexamic Acid Versus Topical Oxymetazoline Spray for Achieving Hemostasis in Epistaxis. The Journal of emergency medicine. 2020;58(2):211-6.
Jervis S, Saunders T, Belcher J, Skinner D. Evaluating three hundred and fifty‐two admissions and predictors of re‐admissions for epistaxis–is it time to re‐evaluate tranexamic acid in epistaxis? Clinical Otolaryngology. 2017;42(2):439-42.
Gaillard S, Dupuis‐Girod S, Boutitie F, Rivière S, Morinière S, Hatron PY, et al. Tranexamic acid for epistaxis in hereditary hemorrhagic telangiectasia patients: a European cross‐over controlled trial in a rare disease. Journal of Thrombosis and Haemostasis. 2014;12(9):1494-502.
Geisthoff UW, Seyfert UT, Kübler M, Bieg B, Plinkert PK, König J. Treatment of epistaxis in hereditary hemorrhagic telangiectasia with tranexamic acid-a double-blind placebo-controlled cross-over phase IIIB study. Thrombosis Research. 2014;134(3):565-71.
Utkewicz MD, Brunetti L, Awad NI. Epistaxis complicated by rivaroxaban managed with topical tranexamic acid. The American journal of emergency medicine. 2015;33(9):1329. e5-. e7.
Tibbelin A, Aust R, Bende M, Holgersson M, Petruson B, Rundcrantz H, et al. Effect of local tranexamic acid gel in the treatment of epistaxis. ORL. 1995;57(4):207-9.
White A, O'reilly B. Oral tranexamic acid in the management of epistaxis. Clinical Otolaryngology & Allied Sciences. 1988;13(1):11-6.
Birmingham AR, Mah ND, Ran R, Hansen M. Topical tranexamic acid for the treatment of acute epistaxis in the emergency department. The American journal of emergency medicine. 2018;36(7):1242-5.
- Abstract Viewed: 613 times
- pdf Downloaded: 322 times